Inventor
LEFKER BRUCE A
US33 patents
⚠️ This page may combine multiple inventors who share the name “LEFKER BRUCE A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PFIZER
31 patentsUS5936089AAug 10, 1999
Dipeptides which promote release of growth hormone
PFIZER139 citations97
US6552067B2Apr 22, 2003
EP4 receptor selective agonists in the treatment of osteoporosis
PFIZER57 citations96
US6747054B2Jun 8, 2004
EP4 receptor selective agonists in the treatment of osteoporosis
PFIZER24 citations92
US6649657B2Nov 18, 2003
Prevention of loss and restoration of bone mass by certain prostaglandin agonists
PFIZER16 citations92
US6498172B1Dec 24, 2002
Prostaglandin agonists and their use to treat bone disorders
PFIZER25 citations92
US6288120B1Sep 11, 2001
Prevention of loss and restoration of bone mass by certain prostaglandin agonists
PFIZER30 citations92
US6124314ASep 26, 2000
Osteoporosis compounds
PFIZER42 citations92
US6124264ASep 26, 2000
Heterocyclic compounds
PFIZER16 citations92
US6110932AAug 29, 2000
Growth hormone secretagogues
PFIZER20 citations92
US6107306AAug 22, 2000
Heterocyclic compounds
PFIZER29 citations92
US5442044AAug 15, 1995
Orally active renin inhibitors
PFIZER39 citations92
US6608203B2Aug 19, 2003
Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
PFIZER13 citations83
US7192979B2Mar 20, 2007
EP4 receptor selective agonist in the treatment of osteoporosis
PFIZER7 citations74
US6376502B1Apr 23, 2002
Osteoporosis compounds
PFIZER6 citations74
US6492412B2Dec 10, 2002
Prevention of loss and restoration of bone mass by certain prostaglandin agonists
PFIZER9 citations73
US6482825B2Nov 19, 2002
Growth-hormone secretagogues
PFIZER7 citations73
US6426359B1Jul 30, 2002
Prevention and treatment of skeletal disorder with EP2 receptor subtype selective prostaglandin E2 agonists
PFIZER12 citations73
US6306875B1Oct 23, 2001
Growth-hormone secretagogues
PFIZER5 citations73
US6642266B2Nov 4, 2003
EP4 receptor selective agonists in the treatment of osteoporosis
PFIZER7 citations72
US6852863B2Feb 8, 2005
Metabolites of (3-{[4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid
PFIZER7 citations71
US7442702B2Oct 28, 2008
Prostaglandin agonists
PFIZER2 citations63
US6998423B2Feb 14, 2006
Prevention of loss and restoration of bone mass by certain prostaglandin agonists
PFIZER2 citations62
US6313140B1Nov 6, 2001
Method of treatment using certain growth-hormone secret agogues
PFIZER2 citations62
US6278000B1Aug 21, 2001
Growth-hormone secretagogues
PFIZER3 citations62
US7576128B2Aug 18, 2009
Androgen receptor modulators
PFIZER5 citations61
US6737437B2May 18, 2004
EP4 receptor selective agonists in the treatment of osteoporosis
PFIZER4 citations61
US7414071B2Aug 19, 2008
Methods of treatment with selective EP4 receptor agonists
PFIZER6 citations60
US7507732B2Mar 24, 2009
Cyclopentapyridine and tetrahydroquinoline derivatives
PFIZER5 citations52
US7670613B2Mar 2, 2010
Androgen modulators
PFIZER0 citations45
US7473711B2Jan 6, 2009
Androgen modulators
PFIZER0 citations40
US7507860B2Mar 24, 2009
Androgen modulators
PFIZER0 citations38